Glucagon and GLP-1 receptor co-agonist

Pemv sc

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

PEMV_SC

Mechanism: Dual agonist (survodutide; mazdutide; cotadutide; efinopegdutide; pemvidutide)
Trials: 0
Participants in these arms: 0

Doses in this pooled treatment

Pemvidutide 1.2 mg subcutaneous once weekly
Pemvidutide 1.8 mg subcutaneous once weekly
Pemvidutide 2.4 mg subcutaneous once weekly

Pemv sc

Doses in this pooled treatment

Trials